Search Results for: prostate cancer

DiagnoCure Inc announced that its proprietary prostate cancer biomarker PCA3 was the topic of over 13 presentations at the 2010 European Association of Urology (EAU) meeting,

Gen-Probe’s PROGENSA PCA3 assay can help predict the outcome of initial prostate biopsies in men suspected of having prostate cancer, according to a study of the molecular urine test presented in a scientific poster last week.

QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.

Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.